| __timestamp | Cytokinetics, Incorporated | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 17268000 | 5078000000 |
| Thursday, January 1, 2015 | 19667000 | 4717000000 |
| Friday, January 1, 2016 | 27823000 | 5096000000 |
| Sunday, January 1, 2017 | 36468000 | 4986000000 |
| Monday, January 1, 2018 | 31282000 | 4214000000 |
| Tuesday, January 1, 2019 | 39610000 | 3806000000 |
| Wednesday, January 1, 2020 | 52820000 | 3671000000 |
| Friday, January 1, 2021 | 96803000 | 3528000000 |
| Saturday, January 1, 2022 | 177977000 | 3445000000 |
| Sunday, January 1, 2023 | 173612000 | 3498000000 |
| Monday, January 1, 2024 | 3702000000 |
Data in motion
In the pharmaceutical industry, operational costs can significantly impact a company's bottom line. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Teva Pharmaceutical Industries Limited and Cytokinetics, Incorporated from 2014 to 2023. Over this period, Teva consistently reported higher SG&A expenses, peaking in 2016 with nearly 5.1 billion USD. In contrast, Cytokinetics, a smaller player, saw its SG&A expenses grow by over 900% from 2014 to 2022, reflecting its aggressive expansion strategy.
Teva's expenses showed a downward trend, decreasing by approximately 32% from 2014 to 2023, indicating a strategic shift towards cost optimization. Meanwhile, Cytokinetics' expenses surged, particularly between 2020 and 2022, highlighting its investment in growth and development. This comparison underscores the diverse strategies employed by pharmaceutical companies in managing operational costs.
AbbVie Inc. and Cytokinetics, Incorporated: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Amgen Inc. and Teva Pharmaceutical Industries Limited
Operational Costs Compared: SG&A Analysis of Gilead Sciences, Inc. and Cytokinetics, Incorporated
Breaking Down SG&A Expenses: argenx SE vs Teva Pharmaceutical Industries Limited
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Cytokinetics, Incorporated
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Teva Pharmaceutical Industries Limited or Supernus Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Catalent, Inc. vs Cytokinetics, Incorporated
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs Cytokinetics, Incorporated
SG&A Efficiency Analysis: Comparing Cytokinetics, Incorporated and Axsome Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Cytokinetics, Incorporated and Geron Corporation
Cytokinetics, Incorporated or Celldex Therapeutics, Inc.: Who Manages SG&A Costs Better?